Amphenol (APH) Financials

Amphenol logo
$75.35 -2.88 (-3.68%)
Closing price 11/16/2026 03:59 PM Eastern
Extended Trading
$75.39 +0.03 (+0.05%)
As of 11/16/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Amphenol

Annual Income Statements for Amphenol

This table shows Amphenol's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
764 823 651 1,205 1,155 1,203 1,580 1,902 1,928 2,424 4,270
Consolidated Net Income / (Loss)
772 833 661 1,217 1,164 1,213 1,591 1,917 1,946 2,442 4,305
Net Income / (Loss) Continuing Operations
772 833 661 1,217 1,164 1,213 1,580 1,917 1,946 2,442 4,305
Total Pre-Tax Income
1,053 1,141 1,352 1,588 1,496 1,527 1,989 2,467 2,455 3,012 5,601
Total Operating Income
1,105 1,205 1,428 1,687 1,619 1,638 2,105 2,586 2,560 3,157 5,869
Total Gross Profit
1,780 2,040 2,310 2,655 2,616 2,664 3,402 4,028 4,084 5,140 8,518
Total Revenue
5,569 6,286 7,011 8,202 8,225 8,599 10,876 12,623 12,555 15,223 23,095
Operating Revenue
5,569 6,286 7,011 8,202 8,225 8,599 10,876 12,623 12,555 15,223 23,095
Total Cost of Revenue
3,789 4,246 4,701 5,547 5,609 5,935 7,475 8,595 8,471 10,083 14,577
Operating Cost of Revenue
3,789 4,246 4,701 5,547 5,609 5,935 7,475 8,595 8,471 10,083 14,577
Total Operating Expenses
675 835 882 968 997 1,026 1,297 1,442 1,525 1,983 2,649
Selling, General & Admin Expense
669 798 878 960 971 1,014 1,226 1,421 1,490 1,855 2,546
Other Operating Expenses / (Income)
- - - - - - - 22 35 - 103
Total Other Income / (Expense), net
-52 -64 -75 -99 -123 -112 -116 -118 -105 -145 -268
Interest Expense
68 73 92 102 132 115 116 128 140 217 368
Other Income / (Expense), net
16 8.50 17 3.20 8.60 3.60 -0.40 10 35 72 100
Income Tax Expense
281 309 692 372 332 313 409 551 509 570 1,295
Net Income / (Loss) Attributable to Noncontrolling Interest
8.80 9.70 10 12 9.00 9.90 11 15 18 18 35
Basic Earnings per Share
$2.47 $2.67 $2.13 $4.00 $1.94 $2.02 $2.66 $1.60 $1.62 $2.01 $3.51
Weighted Average Basic Shares Outstanding
309.10M 308.30M 305.70M 301.20M 595M 596.10M 597.90M 1.19B 1.19B 1.20B 1.22B
Diluted Earnings per Share
$2.41 $2.61 $2.06 $3.85 $1.88 $1.96 $2.54 $1.53 $1.55 $1.92 $3.34
Weighted Average Diluted Shares Outstanding
316.50M 315.20M 316.50M 312.60M 615.90M 615M 625.50M 1.24B 1.24B 1.26B 1.28B
Weighted Average Basic & Diluted Shares Outstanding
309.10M 307.66M 305.40M 301.30M 298.10M 299.58M 598.94M 594.60M 599.85M 1.21B 1.23B
Cash Dividends to Common per Share
$0.53 $0.58 $0.70 $0.88 $0.48 $0.52 $0.64 $0.41 $0.43 $0.55 $0.75

Quarterly Income Statements for Amphenol

This table shows Amphenol's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
549 525 604 746 738 1,091 1,246 1,196 933 1,769 2,034
Consolidated Net Income / (Loss)
552 529 609 752 744 1,101 1,255 1,205 943 1,784 2,055
Net Income / (Loss) Continuing Operations
552 529 609 752 744 1,101 1,255 1,205 943 1,784 2,055
Total Pre-Tax Income
663 664 775 910 963 1,348 1,641 1,649 1,646 2,388 2,829
Total Operating Income
685 699 820 954 1,025 1,419 1,702 1,723 1,832 2,585 3,021
Total Gross Profit
1,089 1,213 1,357 1,481 1,644 2,053 2,359 2,461 2,800 3,548 4,016
Total Revenue
3,256 3,610 4,039 4,318 4,811 5,650 6,194 6,439 7,620 8,758 10,230
Operating Revenue
3,256 3,610 4,039 4,318 4,811 5,650 6,194 6,439 7,620 8,758 10,230
Total Cost of Revenue
2,167 2,397 2,682 2,837 3,167 3,597 3,835 3,978 4,820 5,210 6,214
Operating Cost of Revenue
2,167 2,397 2,682 2,837 3,167 3,597 3,835 3,978 4,820 5,210 6,214
Total Operating Expenses
404 514 537 527 619 635 657 738 968 963 995
Selling, General & Admin Expense
404 444 492 515 575 623 657 691 852 940 980
Other Operating Expenses / (Income)
- 70 - - - 12 0.00 - 117 - 16
Total Other Income / (Expense), net
-22 -35 -45 -43 -62 -71 -61 -74 -186 -196 -192
Interest Expense
38 56 56 67 77 81 81 130 208 214 212
Other Income / (Expense), net
16 21 11 24 15 10 19 56 22 18 21
Income Tax Expense
111 135 166 158 219 247 386 444 702 604 775
Net Income / (Loss) Attributable to Noncontrolling Interest
3.30 3.90 4.50 5.90 6.40 9.50 9.40 9.70 10 15 20
Basic Earnings per Share
$0.46 $0.44 $0.50 $0.62 $0.61 $0.90 $0.51 $0.98 $0.76 $1.44 $0.82
Weighted Average Basic Shares Outstanding
1.20B 1.20B 1.20B 1.20B 1.21B 1.22B 2.44B 1.22B 1.23B 1.23B 2.47B
Diluted Earnings per Share
$0.44 $0.41 $0.48 $0.62 $0.58 $0.86 $0.49 $0.98 $0.72 $1.37 $0.79
Weighted Average Diluted Shares Outstanding
1.26B 1.26B 1.27B 1.26B 1.27B 1.27B 2.57B 1.28B 1.29B 1.29B 2.58B
Weighted Average Basic & Diluted Shares Outstanding
600.60M 1.20B 1.21B 1.21B 1.21B 1.22B 1.22B 1.23B 1.23B 1.23B 2.47B

Annual Cash Flow Statements for Amphenol

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
768 -703 624 -399 -388 811 -505 176 102 1,842 7,814
Net Cash From Operating Activities
1,031 1,078 1,144 1,113 1,502 1,592 1,540 2,175 2,529 2,815 5,375
Net Cash From Continuing Operating Activities
1,031 1,078 1,144 1,113 1,502 1,592 1,524 2,175 2,529 2,815 5,375
Net Income / (Loss) Continuing Operations
772 833 661 1,217 1,164 1,213 1,580 1,917 1,946 2,442 4,305
Consolidated Net Income / (Loss)
772 833 661 1,217 1,164 - 1,580 1,917 1,946 2,442 4,305
Depreciation Expense
172 217 227 300 312 308 396 393 406 573 922
Non-Cash Adjustments To Reconcile Net Income
28 3.20 50 56 77 71 53 90 94 110 135
Changes in Operating Assets and Liabilities, net
59 25 207 -460 -51 0.10 -491 -225 83 -309 12
Net Cash From Investing Activities
-27 -1,613 -380 -442 -1,229 -334 -1,888 -731 -1,394 -2,649 -5,082
Net Cash From Continuing Investing Activities
-27 -1,613 -380 -442 -1,229 -334 -2,604 -731 -1,394 -2,649 -5,082
Purchase of Property, Plant & Equipment
-172 -191 -227 -311 -295 -277 -360 -384 -373 -665 -997
Acquisitions
-200 -1,305 -266 -159 -937 -50 -2,225 -288 -970 -2,156 -3,819
Purchase of Investments
-135 -232 -40 -45 -65 -142 -165 -309 -306 -26 -309
Sale of Property, Plant & Equipment
8.70 7.10 4.10 5.00 7.40 13 3.70 5.60 4.00 7.80 15
Sale and/or Maturity of Investments
471 109 148 67 62 123 156 228 246 190 28
Other Investing Activities, net
- - - 0.00 0.00 -0.60 -14 17 4.90 1.90 0.00
Net Cash From Financing Activities
-180 -134 -140 -1,070 -648 -517 -145 -1,197 -1,012 1,730 7,423
Net Cash From Continuing Financing Activities
-180 -134 -140 -1,070 -648 -517 -145 -1,197 -1,012 1,730 7,423
Repayment of Debt
-218 180 -380 -565 -1,140 -2,367 -126 -215 -651 -391 -490
Repurchase of Common Equity
-249 -326 -618 -935 -602 -641 -662 -731 -585 -689 -665
Payment of Dividends
-165 -180 -229 -272 -323 -313 -366 -487 -525 -628 -808
Issuance of Debt
371 0.00 903 572 1,170 2,510 752 51 355 2,991 8,922
Other Financing Activities, net
81 192 184 131 246 295 256 185 393 447 465
Effect of Exchange Rate Changes
-55 -34 - - - 69 - -71 -21 -54 98
Cash Interest Paid
64 69 84 94 117 105 112 124 129 180 288
Cash Income Taxes Paid
251 247 325 393 408 337 446 478 560 650 1,084

Quarterly Cash Flow Statements for Amphenol

This table details how cash moves in and out of Amphenol's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
382 -605 311 1,754 -1,660 1,550 592 7,331 -7,003 601 -556
Net Cash From Operating Activities
600 664 704 847 765 1,417 1,471 1,722 1,122 1,557 2,079
Net Cash From Continuing Operating Activities
600 664 704 847 765 1,417 1,471 1,722 1,122 1,557 2,079
Net Income / (Loss) Continuing Operations
552 529 609 752 744 1,101 1,255 1,205 943 1,784 2,055
Consolidated Net Income / (Loss)
552 529 609 752 744 1,101 1,255 1,205 943 1,784 2,055
Depreciation Expense
104 124 201 144 236 209 228 249 486 341 348
Non-Cash Adjustments To Reconcile Net Income
24 27 30 30 27 31 37 41 34 45 47
Changes in Operating Assets and Liabilities, net
-80 -15 -136 -78 -242 75 -49 227 -342 -614 -371
Net Cash From Investing Activities
-17 -2,179 -203 -250 -2,353 -612 -614 -1,504 -11,031 -673 -1,276
Net Cash From Continuing Investing Activities
-17 -2,179 -203 -250 -2,353 -612 -614 -1,504 -11,031 -673 -1,276
Purchase of Property, Plant & Equipment
-94 -141 -230 -200 -189 -297 -257 -254 -292 -356 -457
Acquisitions
0.00 -2,100 - -57 -2,172 -311 -289 -1,046 -10,592 -92 -372
Purchase of Investments
-12 -1.50 -7.30 -5.50 -3.10 -9.50 -75 -222 -233 -468 -837
Sale of Property, Plant & Equipment
0.50 4.90 1.70 0.70 4.10 1.60 1.90 7.20 1.30 3.80 1.40
Sale and/or Maturity of Investments
88 58 36 8.00 7.20 4.40 4.70 11 84 242 399
Other Investing Activities, net
1.10 0.80 -2.80 2.80 0.00 - - - 0.00 -2.00 -9.50
Net Cash From Financing Activities
-176 920 -228 1,214 -89 701 -266 7,077 2,898 -313 -1,392
Net Cash From Continuing Financing Activities
-176 920 -228 1,214 -89 701 -266 7,077 2,898 -313 -1,392
Repayment of Debt
-4.00 -362 -1.30 -24 239 -648 -20 -61 -358 -1,184 -933
Repurchase of Common Equity
-154 -190 -176 -169 -181 -160 -153 -171 -178 -208 -245
Payment of Dividends
-132 -150 -136 -211 -200 -202 -205 -202 -307 -308 -312
Other Financing Activities, net
113 121 86 127 53 281 112 20 96 105 97
Effect of Exchange Rate Changes
-24 -9.60 37 - 17 - - 35 8.40 30 33
Cash Interest Paid
33 38 41 67 52 88 50 99 120 256 145
Cash Income Taxes Paid
130 229 157 134 168 335 325 257 348 811 645

Annual Balance Sheets for Amphenol

This table presents Amphenol's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
7,458 8,499 10,004 10,045 10,816 12,327 14,678 15,326 16,526 21,440 36,237
Total Current Assets
3,850 3,591 4,656 4,572 4,211 5,491 5,958 6,479 6,835 9,686 20,267
Cash & Equivalents
1,737 1,035 1,719 1,279 891 1,702 1,197 1,373 1,475 3,317 11,131
Short-Term Investments
23 139 35 12 17 36 44 61 185 18 304
Accounts Receivable
1,105 1,349 1,599 1,792 1,736 1,952 2,455 2,631 2,618 3,288 4,717
Inventories, net
852 929 1,107 1,234 1,310 1,462 1,894 2,094 2,167 2,546 3,425
Prepaid Expenses
- - - 254 256 339 368 320 390 517 691
Plant, Property, & Equipment, net
610 711 817 876 999 1,055 1,175 1,204 1,315 1,712 2,306
Total Noncurrent Assets
2,999 4,196 4,531 4,598 5,605 5,782 7,545 7,643 8,376 10,042 13,664
Goodwill
2,693 3,679 4,043 4,103 4,867 5,032 6,377 6,446 7,092 8,236 10,575
Intangible Assets
306 517 489 398 442 398 757 734 835 1,225 2,241
Other Noncurrent Operating Assets
- - - 96 296 352 411 463 449 581 847
Total Liabilities & Shareholders' Equity
7,458 8,499 10,004 10,045 10,816 12,327 14,678 15,326 16,526 21,440 36,237
Total Liabilities
4,180 4,776 5,961 5,981 6,219 6,875 8,299 8,232 8,100 11,584 22,727
Total Current Liabilities
1,008 1,635 1,579 2,451 2,133 2,304 2,447 2,676 3,153 4,084 6,803
Short-Term Debt
0.30 375 1.10 764 403 230 4.00 2.70 354 402 937
Accounts Payable
588 678 876 891 867 1,121 1,312 1,309 1,351 1,819 2,662
Dividends Payable
43 49 58 69 74 87 120 125 132 200 307
Current Deferred & Payable Income Tax Liabilities
82 125 154 204 128 113 89 170 166 199 483
Current Employee Benefit Liabilities
106 132 152 157 172 291 366 417 413 530 768
Other Current Liabilities
190 276 339 367 489 463 556 653 738 934 1,646
Total Noncurrent Liabilities
3,172 3,140 4,381 3,529 4,087 4,571 5,852 5,556 4,947 7,500 15,924
Long-Term Debt
2,813 2,636 3,542 2,806 3,203 3,636 4,796 4,575 3,984 6,484 14,565
Noncurrent Deferred & Payable Income Tax Liabilities
- 78 241 256 260 299 424 410 367 377 433
Noncurrent Employee Benefit Liabilities
263 288 272 190 199 229 193 128 143 130 138
Other Noncurrent Operating Liabilities
96 139 326 277 424 407 439 443 454 509 789
Redeemable Noncontrolling Interest
- - - - - - 19 21 31 8.70 9.30
Total Equity & Noncontrolling Interests
3,278 3,723 4,043 4,064 4,596 5,452 6,360 7,074 8,396 9,847 13,500
Total Preferred & Common Equity
3,239 3,675 3,990 4,017 4,530 5,385 6,302 7,016 8,347 9,792 13,413
Total Common Equity
3,239 3,675 3,990 4,017 4,530 5,385 6,302 7,016 8,347 9,792 13,413
Common Stock
784 1,021 1,249 1,434 1,684 2,069 2,410 2,651 3,102 3,603 4,234
Retained Earnings
2,804 3,123 2,942 3,029 3,348 3,705 4,279 4,979 5,921 7,105 9,854
Treasury Stock
- - 0.00 -55 - -111 -100 -80 -143 -200 -196
Accumulated Other Comprehensive Income / (Loss)
-350 -469 -201 -390 -431 -278 -287 -535 -534 -716 -480
Noncontrolling Interest
40 48 54 47 66 67 58 58 49 55 87

Quarterly Balance Sheets for Amphenol

This table presents Amphenol's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
16,526 16,723 18,587 19,586 21,440 22,902 25,668 27,143 42,134 44,807 47,022
Total Current Assets
6,835 7,042 6,972 7,773 9,686 9,133 11,299 12,384 15,384 17,817 19,481
Cash & Equivalents
1,475 1,857 1,253 1,563 3,317 1,657 3,207 3,799 4,128 4,729 4,173
Short-Term Investments
185 106 50 20 18 15 19 89 455 690 1,128
Accounts Receivable
2,618 2,501 2,856 3,130 3,288 3,920 4,271 4,544 5,873 6,790 7,782
Inventories, net
2,167 2,153 2,399 2,579 2,546 2,906 3,137 3,300 4,087 4,552 5,265
Prepaid Expenses
390 424 415 480 517 635 664 652 841 1,056 1,134
Plant, Property, & Equipment, net
1,315 1,312 1,534 1,671 1,712 1,855 2,054 2,142 2,689 2,932 3,241
Total Noncurrent Assets
8,376 8,369 10,081 10,142 10,042 11,914 12,316 12,618 24,062 24,058 24,299
Goodwill
7,092 7,101 8,262 8,352 8,236 9,274 9,651 9,869 17,543 17,555 17,696
Intangible Assets
835 785 1,309 1,247 1,225 2,002 1,989 1,982 5,401 5,289 5,344
Other Noncurrent Operating Assets
449 483 511 543 581 638 675 767 1,118 1,214 1,260
Total Liabilities & Shareholders' Equity
16,526 16,723 18,587 19,586 21,440 22,902 25,668 27,143 42,134 44,807 47,022
Total Liabilities
8,100 7,958 9,536 10,059 11,584 12,530 14,069 14,536 28,042 29,185 29,750
Total Current Liabilities
3,153 3,423 3,456 3,902 4,084 4,591 5,604 5,984 8,975 9,438 10,038
Short-Term Debt
354 753 404 403 402 351 937 938 2,110 1,634 701
Accounts Payable
1,351 1,265 1,521 1,763 1,819 2,142 2,373 2,462 3,182 4,009 4,871
Dividends Payable
132 132 132 199 200 200 201 202 307 308 309
Current Deferred & Payable Income Tax Liabilities
166 151 104 124 199 260 193 253 657 351 514
Current Employee Benefit Liabilities
413 351 423 480 530 475 603 689 676 875 1,014
Other Current Liabilities
738 772 870 932 934 1,163 1,297 1,441 2,044 2,261 2,630
Total Noncurrent Liabilities
4,947 4,535 6,081 6,157 7,500 7,939 8,465 8,552 19,068 19,747 19,712
Long-Term Debt
3,984 3,557 5,035 5,081 6,484 6,816 7,126 7,130 16,639 17,177 17,170
Noncurrent Deferred & Payable Income Tax Liabilities
367 371 446 440 377 387 369 378 1,270 1,381 1,372
Noncurrent Employee Benefit Liabilities
143 142 141 147 130 134 149 150 154 159 166
Other Noncurrent Operating Liabilities
454 465 458 489 509 602 822 895 1,005 1,030 1,004
Redeemable Noncontrolling Interest
31 31 20 21 8.70 9.30 10 10 9.10 9.00 9.00
Total Equity & Noncontrolling Interests
8,396 8,734 9,031 9,506 9,847 10,363 11,590 12,597 14,082 15,613 17,263
Total Preferred & Common Equity
8,347 8,682 8,980 9,453 9,792 10,301 11,519 12,520 13,977 15,492 17,124
Total Common Equity
8,347 8,682 8,980 9,453 9,792 10,301 11,519 12,520 13,977 15,492 17,124
Common Stock
3,102 3,225 3,350 3,459 3,603 3,673 3,959 4,094 4,349 4,507 4,621
Retained Earnings
5,921 6,164 6,352 6,751 7,105 7,446 8,135 9,155 10,432 11,645 13,089
Treasury Stock
-143 -104 -74 -237 -200 -174 -105 -221 -310 -256 -211
Accumulated Other Comprehensive Income / (Loss)
-534 -603 -649 -520 -716 -644 -470 -508 -494 -404 -376
Noncontrolling Interest
49 52 51 54 55 62 70 76 106 122 139

Annual Metrics And Ratios for Amphenol

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.18% 12.89% 11.53% 16.98% 0.29% 4.54% 26.48% 16.06% -0.54% 21.25% 51.71%
EBITDA Growth
5.87% 10.68% 16.83% 19.04% -2.51% 0.53% 28.21% 19.53% 0.40% 26.68% 81.27%
EBIT Growth
6.48% 8.26% 19.03% 16.99% -3.69% 0.87% 28.18% 23.33% -0.06% 24.46% 84.85%
NOPAT Growth
6.51% 8.51% -20.69% 85.30% -2.51% 3.35% 28.42% 20.13% 0.98% 26.16% 76.28%
Net Income Growth
7.98% 7.81% -20.65% 84.18% -4.35% 4.24% 31.11% 20.49% 1.50% 25.50% 76.33%
EPS Growth
9.05% 8.30% -21.07% 86.89% -4.35% 4.24% 29.59% 20.49% 1.50% 23.87% 73.96%
Operating Cash Flow Growth
12.87% 4.57% 6.18% -2.75% 35.01% 5.97% -3.26% 41.20% 16.28% 11.31% 90.95%
Free Cash Flow Firm Growth
165.43% -148.16% 217.17% 84.89% -60.67% 231.12% -171.54% 337.24% -32.16% -83.72% 24.02%
Invested Capital Growth
1.66% 28.24% 5.00% 8.85% 14.92% 4.05% 31.18% 3.03% 8.42% 21.10% 31.44%
Revenue Q/Q Growth
0.07% 3.64% 4.36% 3.54% -0.89% 3.30% 5.85% 1.71% 0.71% 6.96% 10.11%
EBITDA Q/Q Growth
0.18% 4.35% 4.08% 5.39% -2.80% 3.78% 5.72% 2.18% 1.27% 8.74% 15.15%
EBIT Q/Q Growth
0.80% 4.28% 4.39% 3.35% -1.65% 3.64% 5.21% 3.04% 1.21% 9.38% 15.51%
NOPAT Q/Q Growth
0.81% 4.39% -33.75% 57.12% -1.49% 3.13% 6.29% 2.92% 0.01% 10.81% 11.66%
Net Income Q/Q Growth
1.02% 4.49% -33.90% 56.98% -1.71% 3.34% 6.56% 2.84% 1.18% 11.42% 11.77%
EPS Q/Q Growth
-1.63% 2.35% -36.42% 51.57% -1.71% 3.34% 2.42% 2.84% 1.18% 6.67% 6.71%
Operating Cash Flow Q/Q Growth
7.35% 2.53% 7.41% -4.27% 3.15% 1.07% 1.96% 12.10% 5.71% 0.19% 19.45%
Free Cash Flow Firm Q/Q Growth
5.45% 17.44% -26.60% 10.18% -22.82% 3.35% -945.22% 97.32% -31.02% 127.07% -65.63%
Invested Capital Q/Q Growth
-2.35% -2.50% -5.58% 0.80% 1.67% 1.70% 9.55% 0.91% 5.77% -0.15% 5.28%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
31.96% 32.45% 32.95% 32.37% 31.80% 30.98% 31.28% 31.91% 32.53% 33.76% 36.88%
EBITDA Margin
23.21% 22.76% 23.84% 24.26% 23.58% 22.68% 22.99% 23.68% 23.90% 24.97% 29.84%
Operating Margin
19.84% 19.17% 20.36% 20.57% 19.69% 19.05% 19.35% 20.48% 20.39% 20.74% 25.41%
EBIT Margin
20.13% 19.31% 20.61% 20.61% 19.79% 19.10% 19.35% 20.56% 20.66% 21.21% 25.84%
Profit (Net Income) Margin
13.87% 13.24% 9.42% 14.84% 14.15% 14.11% 14.63% 15.19% 15.50% 16.04% 18.64%
Tax Burden Percent
73.36% 72.96% 48.85% 76.61% 77.81% 79.48% 79.97% 77.69% 79.25% 81.07% 76.87%
Interest Burden Percent
93.91% 94.02% 93.61% 93.98% 91.90% 92.97% 94.51% 95.05% 94.62% 93.28% 93.84%
Effective Tax Rate
26.64% 27.04% 51.15% 23.39% 22.19% 20.52% 20.57% 22.32% 20.75% 18.93% 23.13%
Return on Invested Capital (ROIC)
18.68% 17.61% 12.13% 21.01% 18.29% 17.32% 18.87% 19.67% 18.78% 20.60% 28.65%
ROIC Less NNEP Spread (ROIC-NNEP)
15.58% 14.48% 10.16% 17.41% 14.54% 13.76% 16.11% 17.03% 16.05% 17.02% 23.58%
Return on Net Nonoperating Assets (RNNOA)
6.17% 6.17% 4.89% 9.01% 8.60% 6.83% 8.02% 8.78% 6.29% 6.11% 8.20%
Return on Equity (ROE)
24.85% 23.78% 17.01% 30.02% 26.88% 24.15% 26.89% 28.45% 25.07% 26.71% 36.85%
Cash Return on Invested Capital (CROIC)
17.03% -7.13% 7.25% 12.53% 4.40% 13.35% -8.10% 16.69% 10.70% 1.51% 1.48%
Operating Return on Assets (OROA)
15.52% 15.21% 15.62% 16.86% 15.61% 14.19% 15.59% 17.30% 16.29% 17.01% 20.70%
Return on Assets (ROA)
10.69% 10.44% 7.14% 12.14% 11.16% 10.49% 11.78% 12.78% 12.22% 12.86% 14.93%
Return on Common Equity (ROCE)
24.57% 23.48% 16.79% 29.65% 26.53% 23.83% 26.56% 28.12% 24.81% 26.50% 36.60%
Return on Equity Simple (ROE_SIMPLE)
23.85% 22.66% 16.56% 30.29% 25.69% 22.53% 25.24% 27.32% 23.31% 24.93% 0.00%
Net Operating Profit after Tax (NOPAT)
810 879 697 1,292 1,260 1,302 1,672 2,009 2,029 2,559 4,511
NOPAT Margin
14.55% 13.99% 9.95% 15.76% 15.32% 15.14% 15.37% 15.91% 16.16% 16.81% 19.53%
Net Nonoperating Expense Percent (NNEP)
3.09% 3.14% 1.97% 3.60% 3.75% 3.56% 2.76% 2.65% 2.73% 3.58% 5.07%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 17.24% 15.93% 15.29% 15.55%
Cost of Revenue to Revenue
68.04% 67.55% 67.05% 67.63% 68.20% 69.02% 68.72% 68.09% 67.47% 66.24% 63.12%
SG&A Expenses to Revenue
12.02% 12.70% 12.53% 11.70% 11.81% 11.79% 11.28% 11.26% 11.87% 12.19% 11.02%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
12.12% 13.28% 12.58% 11.80% 12.12% 11.93% 11.92% 11.43% 12.14% 13.03% 11.47%
Earnings before Interest and Taxes (EBIT)
1,121 1,214 1,445 1,690 1,628 1,642 2,105 2,596 2,594 3,229 5,969
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,293 1,431 1,672 1,990 1,940 1,950 2,500 2,989 3,001 3,801 6,891
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.58 5.25 6.31 5.76 6.78 7.02 8.10 6.34 7.05 8.55 12.33
Price to Tangible Book Value (P/TBV)
61.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 140.27 253.19 277.41
Price to Revenue (P/Rev)
2.66 3.07 3.59 2.82 3.73 4.40 4.69 3.52 4.68 5.50 7.16
Price to Earnings (P/E)
19.43 23.43 38.67 19.20 26.59 31.43 32.29 23.38 30.51 34.54 38.74
Dividend Yield
1.10% 0.93% 0.85% 1.15% 0.93% 0.82% 0.74% 1.08% 0.86% 0.79% 0.55%
Earnings Yield
5.15% 4.27% 2.59% 5.21% 3.76% 3.18% 3.10% 4.28% 3.28% 2.90% 2.58%
Enterprise Value to Invested Capital (EV/IC)
3.64 3.77 4.58 3.97 4.54 5.22 5.43 4.60 5.48 6.42 9.48
Enterprise Value to Revenue (EV/Rev)
2.86 3.37 3.85 3.10 4.07 4.65 5.03 3.78 4.90 5.74 7.34
Enterprise Value to EBITDA (EV/EBITDA)
12.32 14.80 16.15 12.79 17.25 20.52 21.86 15.96 20.52 22.98 24.61
Enterprise Value to EBIT (EV/EBIT)
14.21 17.44 18.69 15.06 20.56 24.37 25.97 18.38 23.73 27.05 28.41
Enterprise Value to NOPAT (EV/NOPAT)
19.66 24.07 38.71 19.70 26.57 30.73 32.69 23.75 30.35 34.13 37.59
Enterprise Value to Operating Cash Flow (EV/OCF)
15.46 19.64 23.60 22.88 22.28 25.14 35.49 21.94 24.35 31.03 31.55
Enterprise Value to Free Cash Flow (EV/FCFF)
21.56 0.00 64.76 33.03 110.41 39.87 0.00 28.00 53.27 464.24 726.77
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.86 0.81 0.88 0.88 0.78 0.71 0.75 0.65 0.51 0.70 1.15
Long-Term Debt to Equity
0.86 0.71 0.88 0.69 0.70 0.67 0.75 0.64 0.47 0.66 1.08
Financial Leverage
0.40 0.43 0.48 0.52 0.59 0.50 0.50 0.52 0.39 0.36 0.35
Leverage Ratio
2.32 2.28 2.38 2.47 2.41 2.30 2.28 2.23 2.05 2.08 2.47
Compound Leverage Factor
2.18 2.14 2.23 2.32 2.21 2.14 2.16 2.12 1.94 1.94 2.32
Debt to Total Capital
46.18% 44.71% 46.70% 46.77% 43.97% 41.49% 42.94% 39.22% 33.98% 41.13% 53.43%
Short-Term Debt to Total Capital
0.00% 5.57% 0.01% 10.01% 4.92% 2.47% 0.04% 0.02% 2.77% 2.40% 3.23%
Long-Term Debt to Total Capital
46.18% 39.14% 46.68% 36.76% 39.05% 39.02% 42.90% 39.20% 31.21% 38.73% 50.20%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.66% 0.72% 0.71% 0.62% 0.80% 0.72% 0.69% 0.67% 0.63% 0.38% 0.33%
Common Equity to Total Capital
53.16% 54.57% 52.59% 52.61% 55.23% 57.79% 56.37% 60.11% 65.39% 58.49% 46.23%
Debt to EBITDA
2.18 2.10 2.12 1.79 1.86 1.98 1.92 1.53 1.45 1.81 2.25
Net Debt to EBITDA
0.81 1.28 1.07 1.15 1.39 1.09 1.42 1.05 0.89 0.93 0.59
Long-Term Debt to EBITDA
2.18 1.84 2.12 1.41 1.65 1.86 1.92 1.53 1.33 1.71 2.11
Debt to NOPAT
3.47 3.42 5.08 2.76 2.86 2.97 2.87 2.28 2.14 2.69 3.44
Net Debt to NOPAT
1.30 2.09 2.57 1.76 2.14 1.63 2.13 1.56 1.32 1.39 0.90
Long-Term Debt to NOPAT
3.47 3.00 5.08 2.17 2.54 2.79 2.87 2.28 1.96 2.53 3.23
Altman Z-Score
4.36 4.42 4.49 4.37 4.88 5.17 5.60 5.38 6.40 6.32 6.37
Noncontrolling Interest Sharing Ratio
1.13% 1.26% 1.31% 1.24% 1.31% 1.32% 1.22% 1.15% 1.02% 0.79% 0.69%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.82 2.20 2.95 1.87 1.97 2.38 2.43 2.42 2.17 2.37 2.98
Quick Ratio
2.84 1.54 2.12 1.26 1.24 1.60 1.51 1.52 1.36 1.62 2.37
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
739 -356 417 771 303 1,004 -718 1,704 1,156 188 233
Operating Cash Flow to CapEx
630.66% 586.61% 514.25% 364.10% 522.36% 602.80% 431.76% 574.99% 685.66% 428.03% 547.43%
Free Cash Flow to Firm to Interest Expense
10.82 -4.90 4.52 7.58 2.30 8.70 -6.22 13.27 8.29 0.87 0.63
Operating Cash Flow to Interest Expense
15.09 14.84 12.40 10.94 11.39 13.80 13.33 16.94 18.13 12.97 14.61
Operating Cash Flow Less CapEx to Interest Expense
12.70 12.31 9.99 7.94 9.21 11.51 10.25 13.99 15.48 9.94 11.94
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.77 0.79 0.76 0.82 0.79 0.74 0.81 0.84 0.79 0.80 0.80
Accounts Receivable Turnover
5.00 5.12 4.76 4.84 4.66 4.66 4.94 4.96 4.78 5.15 5.77
Inventory Turnover
4.41 4.77 4.62 4.74 4.41 4.28 4.45 4.31 3.98 4.28 4.88
Fixed Asset Turnover
9.28 9.52 9.18 9.69 8.77 8.37 9.76 10.61 9.97 10.06 11.50
Accounts Payable Turnover
6.28 6.71 6.05 6.28 6.38 5.97 6.15 6.56 6.37 6.36 6.51
Days Sales Outstanding (DSO)
73.03 71.24 76.73 75.44 78.28 78.27 73.94 73.53 76.31 70.81 63.26
Days Inventory Outstanding (DIO)
82.72 76.53 79.03 77.01 82.77 85.25 81.95 84.67 91.80 85.30 74.75
Days Payable Outstanding (DPO)
58.09 54.41 60.32 58.10 57.17 61.12 59.40 55.66 57.31 57.38 56.10
Cash Conversion Cycle (CCC)
97.65 93.36 95.44 94.34 103.87 102.41 96.49 102.55 110.80 98.73 81.90
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
4,375 5,610 5,890 6,412 7,369 7,667 10,057 10,363 11,235 13,606 17,884
Invested Capital Turnover
1.28 1.26 1.22 1.33 1.19 1.14 1.23 1.24 1.16 1.23 1.47
Increase / (Decrease) in Invested Capital
72 1,235 281 522 957 298 2,390 305 873 2,371 4,278
Enterprise Value (EV)
15,929 21,168 27,000 25,459 33,470 40,021 54,655 47,707 61,571 87,345 169,583
Market Capitalization
14,836 19,282 25,157 23,132 30,706 37,826 51,019 44,485 58,814 83,730 165,419
Book Value per Share
$10.51 $11.91 $13.07 $13.33 $15.28 $18.00 $10.54 $11.79 $13.95 $8.12 $10.96
Tangible Book Value per Share
$0.78 ($1.69) ($1.77) ($1.61) ($2.63) ($0.15) ($1.39) ($0.28) $0.70 $0.27 $0.49
Total Capital
6,092 6,734 7,586 7,635 8,203 9,318 11,179 11,672 12,764 16,742 29,012
Total Debt
2,814 3,011 3,543 3,571 3,607 3,867 4,800 4,578 4,337 6,886 15,502
Total Long-Term Debt
2,813 2,636 3,542 2,806 3,203 3,636 4,796 4,575 3,984 6,484 14,565
Net Debt
1,053 1,838 1,789 2,279 2,698 2,128 3,559 3,144 2,677 3,551 4,068
Capital Expenditures (CapEx)
163 184 223 306 288 264 357 378 369 658 982
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,082 1,158 1,324 1,593 1,573 1,679 2,274 2,372 2,376 2,669 2,967
Debt-free Net Working Capital (DFNWC)
2,842 2,331 3,078 2,885 2,482 3,417 3,515 3,806 4,036 6,004 14,402
Net Working Capital (NWC)
2,842 1,956 3,077 2,120 2,079 3,187 3,511 3,803 3,683 5,602 13,464
Net Nonoperating Expense (NNE)
38 47 37 75 96 89 81 92 83 118 206
Net Nonoperating Obligations (NNO)
1,096 1,887 1,847 2,348 2,773 2,215 3,678 3,268 2,809 3,750 4,375
Total Depreciation and Amortization (D&A)
172 217 227 300 312 308 396 393 406 573 922
Debt-free, Cash-free Net Working Capital to Revenue
19.42% 18.42% 18.88% 19.42% 19.13% 19.52% 20.91% 18.79% 18.93% 17.53% 12.85%
Debt-free Net Working Capital to Revenue
51.03% 37.08% 43.90% 35.17% 30.17% 39.74% 32.32% 30.15% 32.15% 39.44% 62.36%
Net Working Capital to Revenue
51.03% 31.11% 43.88% 25.85% 25.27% 37.06% 32.28% 30.13% 29.33% 36.80% 58.30%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.62 $0.00 $0.00 $0.00 $0.97 $1.01 $1.33 $1.60 $1.62 $2.01 $3.51
Adjusted Weighted Average Basic Shares Outstanding
1.24B 0.00 0.00 0.00 1.19B 1.19B 1.20B 1.19B 1.19B 1.20B 1.22B
Adjusted Diluted Earnings per Share
$0.60 $0.00 $0.00 $0.00 $0.94 $0.98 $1.27 $1.53 $1.56 $1.92 $3.34
Adjusted Weighted Average Diluted Shares Outstanding
1.27B 0.00 0.00 0.00 1.23B 1.23B 1.25B 1.24B 1.24B 1.26B 1.28B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.23B 0.00 0.00 0.00 1.19B 1.20B 1.20B 1.19B 1.20B 1.21B 1.23B
Normalized Net Operating Profit after Tax (NOPAT)
815 906 1,002 1,299 1,280 1,311 1,728 2,009 2,029 2,559 4,511
Normalized NOPAT Margin
14.63% 14.41% 14.29% 15.84% 15.56% 15.25% 15.89% 15.91% 16.16% 16.81% 19.53%
Pre Tax Income Margin
18.91% 18.15% 19.29% 19.37% 18.19% 17.75% 18.29% 19.55% 19.55% 19.79% 24.25%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
16.41 16.72 15.65 16.62 12.34 14.23 18.22 20.22 18.60 14.88 16.23
NOPAT to Interest Expense
11.86 12.11 7.56 12.71 9.55 11.28 14.48 15.64 14.54 11.79 12.27
EBIT Less CapEx to Interest Expense
14.02 14.19 13.24 13.61 10.16 11.94 15.13 17.27 15.95 11.85 13.56
NOPAT Less CapEx to Interest Expense
9.47 9.58 5.15 9.70 7.37 9.00 11.39 12.70 11.90 8.76 9.60
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
21.42% 21.56% 34.72% 22.34% 27.73% 25.76% 22.98% 25.42% 26.96% 25.72% 18.77%
Augmented Payout Ratio
53.65% 60.69% 128.26% 99.19% 79.42% 78.61% 64.58% 63.53% 57.04% 53.96% 34.22%

Quarterly Metrics And Ratios for Amphenol

This table displays calculated financial ratios and metrics derived from Amphenol's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 1,229,214,930.00 1,230,234,445.00 1,232,983,457.00
DEI Adjusted Shares Outstanding
- - - - - - - - 1,229,214,930.00 1,230,234,445.00 2,465,966,914.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.76 1.44 0.83
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.49% 18.20% 26.24% 29.76% 47.74% 56.53% 53.37% 49.12% 58.39% 55.00% 65.14%
EBITDA Growth
16.25% 16.37% 34.36% 37.47% 58.55% 94.19% 88.89% 80.85% 83.38% 79.66% 73.87%
EBIT Growth
17.62% 14.14% 24.52% 39.51% 48.32% 98.44% 107.25% 81.98% 78.33% 82.09% 76.67%
NOPAT Growth
21.92% 14.99% 19.62% 46.33% 38.86% 108.15% 102.23% 59.83% 32.57% 66.65% 68.49%
Net Income Growth
24.69% 13.63% 17.48% 44.84% 34.82% 108.21% 106.13% 60.27% 26.75% 62.07% 63.71%
EPS Growth
22.54% 10.81% 17.07% 44.19% 31.82% 109.76% 102.08% 58.06% 24.14% 59.30% 61.22%
Operating Cash Flow Growth
12.60% 23.81% 13.90% 0.63% 27.59% 113.34% 108.92% 103.31% 46.62% 9.91% 41.32%
Free Cash Flow Firm Growth
-164.94% -1,700.35% -1,372.89% -373.42% -4,122.94% 3.21% 12.77% -90.68% -183.88% -398.30% -432.61%
Invested Capital Growth
6.30% 26.45% 28.29% 21.10% 42.91% 24.90% 24.67% 31.44% 77.78% 76.25% 77.48%
Revenue Q/Q Growth
-2.14% 10.85% 11.89% 6.91% 11.42% 17.45% 9.63% 3.95% 18.34% 14.93% 16.80%
EBITDA Q/Q Growth
-1.34% 4.86% 22.32% 8.63% 13.79% 28.43% 18.98% 4.01% 15.38% 25.82% 15.15%
EBIT Q/Q Growth
0.04% 2.75% 15.36% 17.65% 6.35% 37.48% 20.48% 3.31% 4.22% 40.38% 16.89%
NOPAT Q/Q Growth
5.95% -2.42% 15.68% 22.36% 0.53% 46.27% 12.39% -3.29% -16.62% 83.88% 13.63%
Net Income Q/Q Growth
10.03% -4.22% 15.17% 23.50% -1.04% 47.92% 14.02% -3.98% -21.73% 89.13% 15.17%
EPS Q/Q Growth
4.82% -52.87% 17.07% 29.17% -6.45% 48.28% 12.79% 1.03% -26.53% 90.28% -42.34%
Operating Cash Flow Q/Q Growth
-28.78% 10.78% 6.01% 20.33% -9.70% 85.23% 3.81% 17.09% -34.88% 38.85% 33.48%
Free Cash Flow Firm Q/Q Growth
71.44% -2,235.20% -5.87% 32.94% -154.72% 46.48% 4.59% -46.59% -279.22% 6.05% -1.98%
Invested Capital Q/Q Growth
0.07% 18.48% 2.30% -0.15% 18.09% 3.55% 2.11% 5.28% 59.72% 2.65% 2.82%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
33.44% 33.61% 33.60% 34.29% 34.17% 36.34% 38.09% 38.22% 36.75% 40.51% 39.26%
EBITDA Margin
24.71% 23.37% 25.55% 25.96% 26.52% 29.00% 31.47% 31.49% 30.70% 33.61% 33.13%
Operating Margin
21.03% 19.36% 20.29% 22.09% 21.30% 25.11% 27.48% 26.75% 24.04% 29.51% 29.53%
EBIT Margin
21.52% 19.95% 20.57% 22.63% 21.60% 25.29% 27.79% 27.62% 24.33% 29.71% 29.73%
Profit (Net Income) Margin
16.95% 14.65% 15.08% 17.42% 15.47% 19.48% 20.26% 18.72% 12.38% 20.37% 20.09%
Tax Burden Percent
83.30% 79.65% 78.57% 82.60% 77.29% 81.66% 76.49% 73.10% 57.32% 74.70% 72.62%
Interest Burden Percent
94.56% 92.18% 93.29% 93.15% 92.64% 94.34% 95.31% 92.71% 88.78% 91.79% 93.02%
Effective Tax Rate
16.70% 20.35% 21.43% 17.40% 22.71% 18.34% 23.51% 26.90% 42.68% 25.30% 27.38%
Return on Invested Capital (ROIC)
20.61% 17.31% 18.71% 22.36% 20.23% 25.76% 28.80% 28.68% 15.99% 27.83% 30.07%
ROIC Less NNEP Spread (ROIC-NNEP)
19.96% 16.54% 17.68% 21.27% 19.06% 24.52% 27.69% 27.35% 14.94% 26.27% 28.46%
Return on Net Nonoperating Assets (RNNOA)
7.01% 7.17% 6.87% 7.63% 8.14% 11.05% 10.61% 9.51% 12.31% 18.08% 16.44%
Return on Equity (ROE)
27.62% 24.48% 25.58% 29.99% 28.37% 36.81% 39.41% 38.20% 28.31% 45.91% 46.51%
Cash Return on Invested Capital (CROIC)
13.43% -4.89% -5.73% 1.51% -14.97% 0.44% 4.44% 1.48% -34.56% -31.03% -28.51%
Operating Return on Assets (OROA)
17.21% 15.80% 16.56% 18.15% 18.30% 21.51% 24.95% 22.12% 19.38% 24.46% 26.50%
Return on Assets (ROA)
13.56% 11.60% 12.14% 13.97% 13.10% 16.57% 18.19% 14.99% 9.86% 16.77% 17.90%
Return on Common Equity (ROCE)
27.34% 24.26% 25.35% 29.76% 28.14% 36.54% 39.13% 37.93% 28.09% 45.55% 46.14%
Return on Equity Simple (ROE_SIMPLE)
23.47% 23.39% 23.18% 0.00% 25.57% 27.83% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
570 557 644 788 792 1,159 1,302 1,259 1,050 1,931 2,194
NOPAT Margin
17.52% 15.42% 15.94% 18.25% 16.46% 20.50% 21.02% 19.56% 13.78% 22.04% 21.45%
Net Nonoperating Expense Percent (NNEP)
0.65% 0.77% 1.03% 1.09% 1.17% 1.24% 1.11% 1.33% 1.06% 1.56% 1.61%
Return On Investment Capital (ROIC_SIMPLE)
- - - 4.71% 4.52% 5.90% 6.30% 4.34% 3.20% 5.61% 6.24%
Cost of Revenue to Revenue
66.56% 66.39% 66.40% 65.71% 65.83% 63.66% 61.91% 61.78% 63.25% 59.49% 60.74%
SG&A Expenses to Revenue
12.41% 12.31% 12.18% 11.92% 11.96% 11.02% 10.61% 10.73% 11.17% 10.73% 9.58%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
12.41% 14.25% 13.31% 12.20% 12.87% 11.23% 10.61% 11.47% 12.71% 11.00% 9.73%
Earnings before Interest and Taxes (EBIT)
701 720 831 977 1,039 1,429 1,722 1,779 1,854 2,602 3,042
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
805 844 1,032 1,121 1,276 1,638 1,949 2,028 2,339 2,944 3,389
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.94 9.01 8.30 8.55 7.71 10.37 12.07 12.33 11.11 14.00 12.14
Price to Tangible Book Value (P/TBV)
86.61 0.00 0.00 253.19 0.00 0.00 225.71 277.41 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.37 6.04 5.51 5.50 4.73 6.35 7.20 7.16 6.00 7.48 6.29
Price to Earnings (P/E)
34.11 38.83 36.08 34.54 30.40 37.57 39.54 38.74 34.78 42.17 35.04
Dividend Yield
0.75% 0.65% 0.76% 0.79% 0.92% 0.67% 0.53% 0.55% 0.66% 0.52% 0.59%
Earnings Yield
2.93% 2.58% 2.77% 2.90% 3.29% 2.66% 2.53% 2.58% 2.88% 2.37% 2.85%
Enterprise Value to Invested Capital (EV/IC)
6.35 6.39 6.05 6.42 5.29 7.48 9.15 9.48 5.94 7.86 7.32
Enterprise Value to Revenue (EV/Rev)
5.56 6.36 5.79 5.74 5.07 6.61 7.41 7.34 6.55 7.94 6.68
Enterprise Value to EBITDA (EV/EBITDA)
22.91 26.34 23.58 22.98 19.90 24.54 25.96 24.61 21.32 24.89 20.62
Enterprise Value to EBIT (EV/EBIT)
26.43 30.53 27.93 27.05 23.83 29.08 30.06 28.41 25.00 28.96 23.78
Enterprise Value to NOPAT (EV/NOPAT)
33.47 38.63 35.70 34.13 30.57 36.76 38.45 37.59 35.44 41.49 34.24
Enterprise Value to Operating Cash Flow (EV/OCF)
27.48 31.26 29.35 31.03 28.52 33.32 34.53 31.55 29.59 39.25 34.05
Enterprise Value to Free Cash Flow (EV/FCFF)
48.68 0.00 0.00 464.24 0.00 1,884.75 228.84 726.77 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.49 0.60 0.58 0.70 0.69 0.70 0.64 1.15 1.33 1.20 1.03
Long-Term Debt to Equity
0.41 0.56 0.53 0.66 0.66 0.61 0.57 1.08 1.18 1.10 0.99
Financial Leverage
0.35 0.43 0.39 0.36 0.43 0.45 0.38 0.35 0.82 0.69 0.58
Leverage Ratio
1.99 2.03 2.02 2.08 2.07 2.14 2.11 2.47 2.66 2.59 2.48
Compound Leverage Factor
1.88 1.87 1.89 1.93 1.92 2.02 2.01 2.29 2.36 2.38 2.31
Debt to Total Capital
32.96% 37.54% 36.53% 41.13% 40.86% 41.00% 39.02% 53.43% 57.09% 54.63% 50.85%
Short-Term Debt to Total Capital
5.76% 2.79% 2.69% 2.40% 2.00% 4.76% 4.54% 3.23% 6.42% 4.75% 1.99%
Long-Term Debt to Total Capital
27.21% 34.75% 33.85% 38.73% 38.86% 36.24% 34.49% 50.20% 50.67% 49.88% 48.86%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.64% 0.49% 0.50% 0.38% 0.41% 0.41% 0.42% 0.33% 0.35% 0.38% 0.42%
Common Equity to Total Capital
66.40% 61.97% 62.97% 58.49% 58.73% 58.59% 60.56% 46.23% 42.56% 44.99% 48.73%
Debt to EBITDA
1.38 1.68 1.57 1.81 1.68 1.59 1.35 2.25 2.36 2.03 1.67
Net Debt to EBITDA
0.75 1.28 1.12 0.93 1.29 0.95 0.70 0.59 1.78 1.45 1.17
Long-Term Debt to EBITDA
1.14 1.56 1.45 1.71 1.60 1.41 1.19 2.11 2.09 1.86 1.60
Debt to NOPAT
2.02 2.47 2.37 2.69 2.58 2.38 2.00 3.44 3.92 3.39 2.77
Net Debt to NOPAT
1.10 1.88 1.69 1.39 1.98 1.43 1.03 0.90 2.96 2.41 1.95
Long-Term Debt to NOPAT
1.67 2.28 2.20 2.53 2.45 2.11 1.76 3.23 3.48 3.09 2.66
Altman Z-Score
6.88 6.65 6.27 5.97 5.38 6.72 7.97 5.99 4.61 5.89 5.74
Noncontrolling Interest Sharing Ratio
1.00% 0.90% 0.89% 0.79% 0.81% 0.73% 0.73% 0.69% 0.76% 0.77% 0.78%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.06 2.02 1.99 2.37 1.99 2.02 2.07 2.98 1.71 1.89 1.94
Quick Ratio
1.30 1.20 1.21 1.62 1.22 1.34 1.41 2.37 1.17 1.29 1.30
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-95 -2,230 -2,361 -1,583 -4,033 -2,158 -2,059 -3,019 -11,448 -10,755 -10,968
Operating Cash Flow to CapEx
639.13% 486.88% 308.37% 425.46% 414.58% 479.46% 576.11% 698.66% 386.32% 442.76% 456.01%
Free Cash Flow to Firm to Interest Expense
-2.51 -39.61 -42.38 -23.66 -52.71 -26.68 -25.52 -23.27 -55.06 -50.33 -51.66
Operating Cash Flow to Interest Expense
15.73 11.80 12.64 12.66 10.00 17.51 18.23 13.28 5.39 7.29 9.79
Operating Cash Flow Less CapEx to Interest Expense
13.27 9.37 8.54 9.69 7.59 13.86 15.06 11.38 4.00 5.64 7.64
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.80 0.79 0.81 0.80 0.85 0.85 0.90 0.80 0.80 0.82 0.89
Accounts Receivable Turnover
5.23 5.05 4.99 5.15 5.23 5.28 5.47 5.77 5.29 5.25 5.36
Inventory Turnover
4.04 4.07 4.05 4.28 4.38 4.44 4.57 4.88 4.64 4.64 4.72
Fixed Asset Turnover
10.05 9.59 9.76 10.06 10.60 10.49 11.00 11.50 11.40 11.64 12.28
Accounts Payable Turnover
7.04 6.78 6.29 6.36 6.51 6.31 6.36 6.51 6.10 5.59 5.51
Days Sales Outstanding (DSO)
69.85 72.21 73.11 70.81 69.85 69.11 66.78 63.26 69.00 69.58 68.07
Days Inventory Outstanding (DIO)
90.28 89.73 90.12 85.30 83.31 82.25 79.85 74.75 78.64 78.64 77.30
Days Payable Outstanding (DPO)
51.88 53.85 58.03 57.38 56.11 57.86 57.39 56.10 59.87 65.28 66.19
Cash Conversion Cycle (CCC)
108.25 108.10 105.21 98.73 97.06 93.50 89.23 81.90 87.77 82.94 79.18
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
11,243 13,320 13,627 13,606 16,067 16,637 16,988 17,884 28,565 29,322 30,149
Invested Capital Turnover
1.18 1.12 1.17 1.23 1.23 1.26 1.37 1.47 1.16 1.26 1.40
Increase / (Decrease) in Invested Capital
666 2,787 3,005 2,371 4,825 3,317 3,361 4,278 12,498 12,685 13,162
Enterprise Value (EV)
71,334 85,133 82,447 87,345 85,001 124,364 155,355 169,583 169,592 230,438 220,598
Market Capitalization
68,905 80,925 78,471 83,730 79,435 119,448 151,089 165,419 155,311 216,915 207,881
Book Value per Share
$14.47 $14.95 $7.85 $8.12 $8.51 $9.52 $10.25 $10.96 $11.37 $12.59 $13.89
Tangible Book Value per Share
$1.33 ($0.98) ($0.12) $0.27 ($0.80) ($0.10) $0.55 $0.49 ($7.30) ($5.98) ($4.80)
Total Capital
13,074 14,490 15,011 16,742 17,539 19,662 20,674 29,012 32,840 34,433 35,142
Total Debt
4,309 5,439 5,484 6,886 7,167 8,062 8,067 15,502 18,749 18,811 17,871
Total Long-Term Debt
3,557 5,035 5,081 6,484 6,816 7,126 7,130 14,565 16,639 17,177 17,170
Net Debt
2,346 4,137 3,901 3,551 5,495 4,836 4,179 4,068 14,166 13,392 12,569
Capital Expenditures (CapEx)
94 136 228 199 185 296 255 247 290 352 456
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,408 2,618 2,691 2,669 3,221 3,405 3,450 2,967 3,936 4,594 4,842
Debt-free Net Working Capital (DFNWC)
4,371 3,920 4,274 6,004 4,893 6,631 7,338 14,402 8,519 10,013 10,144
Net Working Capital (NWC)
3,619 3,516 3,871 5,602 4,542 5,694 6,400 13,464 6,409 8,379 9,443
Net Nonoperating Expense (NNE)
18 28 35 36 48 58 47 54 107 147 139
Net Nonoperating Obligations (NNO)
2,478 4,270 4,100 3,750 5,695 5,037 4,381 4,375 14,473 13,700 12,878
Total Depreciation and Amortization (D&A)
104 124 201 144 236 209 228 249 486 341 348
Debt-free, Cash-free Net Working Capital to Revenue
18.76% 19.55% 18.91% 17.53% 19.20% 18.09% 16.45% 12.85% 15.19% 15.84% 14.65%
Debt-free Net Working Capital to Revenue
34.05% 29.27% 30.03% 39.44% 29.16% 35.24% 34.98% 62.36% 32.89% 34.51% 30.70%
Net Working Capital to Revenue
28.19% 26.25% 27.20% 36.80% 27.07% 30.26% 30.51% 58.30% 24.74% 28.88% 28.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.46 $0.44 $0.50 $0.62 $0.61 $0.90 $1.02 $0.98 $0.76 $1.44 $0.82
Adjusted Weighted Average Basic Shares Outstanding
1.20B 1.20B 1.20B 1.20B 1.21B 1.22B 1.22B 1.22B 1.23B 1.23B 2.47B
Adjusted Diluted Earnings per Share
$0.44 $0.41 $0.48 $0.62 $0.58 $0.86 $0.97 $0.98 $0.72 $1.37 $0.79
Adjusted Weighted Average Diluted Shares Outstanding
1.26B 1.26B 1.27B 1.26B 1.27B 1.27B 1.28B 1.28B 1.29B 1.29B 2.58B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.62 $0.00 $0.00 $0.00 $0.98 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.20B 1.20B 1.21B 1.21B 1.21B 1.22B 1.22B 1.23B 1.23B 1.23B 2.47B
Normalized Net Operating Profit after Tax (NOPAT)
570 612 644 788 792 1,168 1,302 1,259 1,050 1,948 2,194
Normalized NOPAT Margin
17.52% 16.96% 15.94% 18.25% 16.46% 20.68% 21.02% 19.56% 13.78% 22.24% 21.45%
Pre Tax Income Margin
20.35% 18.39% 19.19% 21.08% 20.01% 23.86% 26.49% 25.61% 21.60% 27.27% 27.66%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
18.39 12.79 14.91 14.61 13.59 17.66 21.33 13.71 8.92 12.18 14.33
NOPAT to Interest Expense
14.97 9.89 11.56 11.78 10.35 14.32 16.13 9.71 5.05 9.03 10.33
EBIT Less CapEx to Interest Expense
15.93 10.37 10.82 11.63 11.18 14.01 18.17 11.81 7.52 10.53 12.18
NOPAT Less CapEx to Interest Expense
12.51 7.46 7.46 8.80 7.94 10.67 12.97 7.81 3.65 7.39 8.19
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
25.83% 26.16% 25.49% 25.72% 26.42% 23.33% 21.21% 18.77% 20.32% 19.69% 18.85%
Augmented Payout Ratio
53.90% 55.14% 54.50% 53.96% 53.62% 44.73% 38.41% 34.22% 35.02% 33.38% 32.24%

Financials Breakdown Chart

Key Financial Trends

Amphenol’s Q2 2026 results show strong operating momentum, although the balance sheet now carries substantially more debt and acquisition-related assets. Revenue reached $8.76 billion, up 55.0% from the restated $5.65 billion reported in Q2 2025 and 14.9% from Q1 2026. Net income attributable to common shareholders rose to $1.77 billion from $1.09 billion a year earlier, while diluted EPS increased to $1.37 from $0.86.

Profitability has improved significantly across the periods provided. Q2 2026 gross margin was approximately 40.5%, compared with 36.3% in Q2 2025 and 33.6% in Q2 2024. Operating margin reached 29.5%, versus 25.1% and 19.4% in those respective quarters. The improvement suggests that revenue growth, scale benefits and acquisition contributions are more than offsetting higher operating expenses.

Cash generation remains a major strength. Operating cash flow was $1.56 billion in Q2 2026, up from $1.42 billion in Q2 2025 and $664.1 million in Q2 2024. After $355.5 million of capital expenditures, estimated free cash flow was approximately $1.20 billion. Amphenol also ended Q2 with $4.73 billion of cash and $689.7 million of short-term investments.

  • Revenue and earnings have followed a strong upward trend, with Q2 2026 revenue up 55% year over year and common-shareholder net income up roughly 62%.
  • Gross and operating margins have expanded meaningfully since 2024, reaching approximately 40.5% and 29.5%, respectively, in Q2 2026.
  • Operating cash flow has remained positive in every reported quarter and reached $1.56 billion in Q2 2026.
  • Estimated Q2 free cash flow of approximately $1.20 billion provided funding for dividends, share repurchases and capital investment.
  • Cash and short-term investments totaled approximately $5.41 billion at Q2 2026, supporting liquidity despite the company’s expanded debt load.
  • Amphenol continued returning capital to shareholders through $307.9 million of dividends and $208.0 million of share repurchases in Q2 2026.
  • Acquisitions remain a central growth strategy. Investing cash outflows included $10.46 billion of acquisitions in Q4 2025, $10.59 billion in Q1 2026 and $92.2 million in Q2 2026, while goodwill and intangible assets totaled $22.84 billion at the latest quarter.
  • Working capital was a use of cash in Q2 2026, with changes in operating assets and liabilities reducing operating cash flow by $613.8 million. Accounts receivable and inventory also increased sequentially.
  • Total debt increased to approximately $19.81 billion at Q2 2026 from about $8.06 billion at Q2 2025, reflecting acquisition financing and other borrowing.
  • Interest expense rose to $213.7 million in Q2 2026 from $80.9 million in Q2 2025, creating a larger fixed cost and making future earnings more sensitive to interest rates and debt reduction.

The balance sheet has expanded rapidly: total assets reached $44.81 billion at Q2 2026, compared with $25.67 billion at Q2 2025 and $18.59 billion at Q2 2024. Current assets of $17.82 billion exceeded current liabilities of $9.44 billion, producing a current ratio of approximately 1.9. However, goodwill and intangible assets represented more than half of total assets, increasing the importance of successful integration and continued earnings growth.

Overall, the statements point to a company with accelerating revenue, improving margins and robust cash generation. The principal investor concern is leverage: Amphenol’s acquisition-led expansion has materially increased debt and interest costs. Investors should monitor whether operating cash flow continues to grow quickly enough to reduce debt while still supporting capital returns and additional acquisitions.

11/17/26 03:55 AM ETAI Generated. May Contain Errors.

Amphenol Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amphenol's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Amphenol's net income appears to be on an upward trend, with a most recent value of $4.31 billion in 2025, rising from $772.30 million in 2015. The previous period was $2.44 billion in 2024. View Amphenol's forecast to see where analysts expect Amphenol to go next.

Amphenol's total operating income in 2025 was $5.87 billion, based on the following breakdown:
  • Total Gross Profit: $8.52 billion
  • Total Operating Expenses: $2.65 billion

Over the last 10 years, Amphenol's total revenue changed from $5.57 billion in 2015 to $23.09 billion in 2025, a change of 314.7%.

In the past 11 quarters, Amphenol's cash and equivalents has ranged from $1.25 billion in Q2 2024 to $4.73 billion in Q2 2026, and is currently $4.17 billion as of their latest financial filing in Q3 2026.

Amphenol had total debt of $15.50 billion at the end of 2025, a 125.1% increase from 2024, and a 451.0% increase since 2015.

Over the last 10 years, Amphenol's book value per share changed from 10.51 in 2015 to 10.96 in 2025, a change of 4.3%.



Financial statements for NYSE:APH last updated on 10/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners